FDA names health facilities getting medicine from Massachusetts pharmacy under investigation

TULSA - The Food and Drug Administration has released a list of medical facilities across the country that received shipments of the injectable steroid linked to the deadly meningitis outbreak.

There is also new information about the conditions at the Massachusetts pharmacy that produced it.

The FDA says six facilities in Tulsa have received shipments of medication from the New England Compounding Center.

2NEWS poured over hundreds of pages of information Wednesday morning and we can report  that none of those six facilities in our area received the steroid in question according to the FDA's information.

Still, the FDA is urging any health care providers who received any medication from the pharmacy to pull those shipments and set them aside.

The Tulsa Health Department says meningitis-infected medicine is very rare. There are no reported cases in Oklahoma.

Epidemiologist Kelly Vanbuskirk said if a patient has a concern, "we refer them to their doctor. Their doctors are the ones that are going to know if they have received products. At this time, we don't have any information it's been sent to Oklahoma."

Officials in Massachusetts are now moving to revoke the pharmacy's license after multiple health and safety violations were discovered there.

So far, 24 people have died since the meningitis outbreak began.